Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Hatakeyama

Showing results (31-40 of 415) with videos related to

Pageof 42
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|January 20, 2019
Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter studyTeppei Matsumoto, Shingo Hatakeyama, Takuma Narita, et al.
Urology|December 9, 2009
Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomesTakuya Koie, Shingo Hatakeyama, Takahiro Yoneyama, et al.
International Journal of Clinical Oncology|May 27, 2015
Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancerTakahiro Yoneyama, Atsushi Imai, Shingo Hatakeyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 29, 2021
Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinomaKai Ozaki, Shingo Hatakeyama, Tomoko Hamaya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 8, 2022
Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective studyToshikazu Tanaka, Shingo Hatakeyama, Daisuke Noro, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 14, 2022
Impact of body size on skin-related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective studyDaichi Sasaki, Shingo Hatakeyama, Toshikazu Tanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 9, 2020
Prognosis of metastatic castration-resistant prostate cancer in the era of the second-generation androgen receptor-targeted agents: A retrospective multicenter studyHiromichi Iwamura, Shingo Hatakeyama, Shintaro Narita, et al.
The Journal of Urology|May 10, 2005
Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infectionShingo Minagawa, Chikara Ohyama, Shingo Hatakeyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 21, 2006
Experience and functional outcome of modified ileal neobladder in 95 patientsTakuya Koie, Shingo Hatakeyama, Takahiro Yoneyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 17, 2019
Validation and development of the CHAARTED criteria in patients with hormone-naïve metastatic prostate cancer: A multi-institutional retrospective study in JapanTeppei Okamoto, Shingo Hatakeyama, Shintaro Narita, et al.
Pageof 42

Showing results (31-40 of 415) with videos related to

Sort By:
Pageof 42
International Journal of Urology : Official Journal of the Japanese Urological Association|January 20, 2019
Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter studyTeppei Matsumoto, Shingo Hatakeyama, Takuma Narita, et al.
Urology|December 9, 2009
Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomesTakuya Koie, Shingo Hatakeyama, Takahiro Yoneyama, et al.
International Journal of Clinical Oncology|May 27, 2015
Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancerTakahiro Yoneyama, Atsushi Imai, Shingo Hatakeyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 29, 2021
Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinomaKai Ozaki, Shingo Hatakeyama, Tomoko Hamaya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 8, 2022
Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective studyToshikazu Tanaka, Shingo Hatakeyama, Daisuke Noro, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 14, 2022
Impact of body size on skin-related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective studyDaichi Sasaki, Shingo Hatakeyama, Toshikazu Tanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 9, 2020
Prognosis of metastatic castration-resistant prostate cancer in the era of the second-generation androgen receptor-targeted agents: A retrospective multicenter studyHiromichi Iwamura, Shingo Hatakeyama, Shintaro Narita, et al.
The Journal of Urology|May 10, 2005
Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infectionShingo Minagawa, Chikara Ohyama, Shingo Hatakeyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 21, 2006
Experience and functional outcome of modified ileal neobladder in 95 patientsTakuya Koie, Shingo Hatakeyama, Takahiro Yoneyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 17, 2019
Validation and development of the CHAARTED criteria in patients with hormone-naïve metastatic prostate cancer: A multi-institutional retrospective study in JapanTeppei Okamoto, Shingo Hatakeyama, Shintaro Narita, et al.
Pageof 42